The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksULS.L Regulatory News (ULS)

  • There is currently no data for ULS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

20 Apr 2020 16:42

RNS Number : 2508K
ULS Technology PLC
20 April 2020
 

 

ULS Technology Plc

 

Directors' Dealings & Holdings in Company

ULS Technology plc (LSE:ULS, "Company" or "ULS") received notification on 20 April 2020 from Kestrel Partners LLP ("Kestrel") that on the 16 April 2020 and 17 April 2020 it purchased for its discretionary clients, 48,732 ordinary shares of 0.4p each ("Shares") in the Company at an average price of £0.42682 per share. The notification also included the matters set out below.

Mr Scott, a non-executive director of ULS, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in ULS.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 11,089,434 Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest hold 6,125,739 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 17,215,173 Shares in the Company, which represents 26.54% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

11,089,434

17.09%

Indirect

JIM Nominees Limited

1,167,569

1.80%

Indirect

Bank of New York Nominees Ltd

4,844,670

7.48%

Indirect

Bank of New York Nominees Ltd

113,500

0.17%

 

For further information contact:

 

ULS Technology plc +44 (0) 1844 262392

John Williams, Finance Director

Steve Goodall, Chief Executive Officer

 

Numis Securities Limited (NOMAD and Broker) +44 (0) 20 7260 1000

Stuart Skinner

Paul Gillam

 

Walbrook PR Limited +44 (0) 20 7933 8780

Tom Cooper

Nick Rome

Nicholas Johnson

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP ('Kestrel')

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Rupert Andrew Scott (non-executive director of ULS Technology plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

ULS Technology plc

b)

 

LEI

 

 

213800TDUOUSIQT2OT29

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

0.4p Ordinary Shares

 

 

 

ISIN: GB00BNG8T458

 

b)

 

Nature of the transaction

 

Purchase

c)

 

Price(s) and volume(s)

 

Purchase:

16 April 2020

Price(s)

 

Volume(s)

GBP 0.42

 

10,000 shares

 

17 April 2020

Price(s)

 

Volume(s)

GBP 0.4285775

 

38,732 shares

 

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

Total Purchase of 48,732 shares in total at an average of £0.426817 per share (total price £20,799.66).

 

 

e)

 

Date of the transaction

 

 16/04/20 & 17/04/20

f)

 

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFVESTIIFII
Date   Source Headline
14th Dec 20203:27 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSDirector/PDMR Shareholding
10th Dec 202010:05 amRNSDirector/PDMR Shareholding
8th Dec 20207:00 amRNSHalf-year Report
1st Dec 20207:00 amRNSNotice of Results
30th Nov 20207:00 amRNS£27m Disposal of Conveyancing Alliance
28th Oct 20207:00 amRNSTrading Update
26th Oct 20207:00 amRNSAppointment of New CEO
21st Oct 20204:08 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSBoard Changes
4th Sep 20202:51 pmRNSHolding(s) in Company
18th Aug 20203:28 pmRNSDirector/PDMR Shareholding
13th Aug 20205:53 pmRNSDirector/PDMR Shareholding
11th Aug 20205:22 pmRNSDirector/PDMR Shareholding
10th Aug 20209:09 amRNSDirector/PDMR Shareholding
6th Aug 20205:09 pmRNSDirector/PDMR Shareholding
4th Aug 20205:28 pmRNSDirector/PDMR Shareholding
30th Jul 20206:21 pmRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSDirector/PDMR Shareholding
28th Jul 202010:27 amRNSResult of AGM
28th Jul 20207:00 amRNSAGM Statement
27th Jul 202011:34 amRNSDirector/PDMR Shareholding
23rd Jul 20206:18 pmRNSDirector/PDMR Shareholding
22nd Jul 202011:28 amRNSDirector/PDMR Shareholding
21st Jul 20206:06 pmRNSDirector/PDMR Shareholding
20th Jul 20203:32 pmRNSDirector/PDMR Shareholding
17th Jul 202011:00 amRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSGrant of Options
13th Jul 20207:00 amRNSExclusive Partnership with Openwork
6th Jul 20208:49 amRNSLloyds Banking Group Contract
3rd Jul 20207:00 amRNSPosting of Annual Report & Notice of AGM
24th Jun 20207:00 amRNSFinal Results
11th Jun 20207:00 amRNSInvestor Presentation
9th Jun 20207:00 amRNSNotice of Results
22nd May 20206:04 pmRNSDirector/PDMR Shareholding
20th May 20202:53 pmRNSDirector/PDMR Shareholding
19th May 20202:21 pmRNSDirector/PDMR Shareholding
15th May 20203:49 pmRNSHolding(s) in Company
15th May 20203:48 pmRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSDirector/PDMR Shareholding
12th May 20206:00 pmRNSDirector/PDMR Shareholding
6th May 20202:20 pmRNSDirector/PDMR Shareholding
6th May 20207:00 amRNSTrading Update
20th Apr 20204:42 pmRNSDirector/PDMR Shareholding
16th Apr 20205:02 pmRNSDirector/PDMR Shareholding
14th Apr 20203:52 pmRNSDirector/PDMR Shareholding
9th Apr 20202:45 pmRNSDirector/PDMR Shareholding
7th Apr 20205:48 pmRNSHolding(s) in Company
7th Apr 20205:48 pmRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSTrading & COVID-19 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.